Stock analysts at StockNews.com assumed coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a report released on Sunday. The brokerage set a "buy" rating on the stock.

LifeVantage Stock Down 0.3 %

LFVN opened at $3.94 on Friday. The company has a market cap of $49.45 million, a price-to-earnings ratio of 16.42 and a beta of 1.22. LifeVantage has a 52-week low of $3.59 and a 52-week high of $7.77. The firm's fifty day simple moving average is $4.13 and its two-hundred day simple moving average is $4.43.

Hedge Funds Weigh In On LifeVantage

Several hedge funds and other institutional investors have recently modified their holdings of the business. Renaissance Technologies LLC lifted its stake in shares of LifeVantage by 0.3% in the second quarter. Renaissance Technologies LLC now owns 974,318 shares of the company's stock worth $4,238,000 after buying an additional 3,300 shares in the last quarter. Dimensional Fund Advisors LP increased its position in LifeVantage by 4.6% during the first quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company's stock worth $1,293,000 after purchasing an additional 11,964 shares during the last quarter. BlackRock Inc. increased its position in LifeVantage by 10.5% during the first quarter. BlackRock Inc. now owns 249,547 shares of the company's stock worth $1,188,000 after purchasing an additional 23,788 shares during the last quarter. Acadian Asset Management LLC increased its position in LifeVantage by 10.5% during the fourth quarter. Acadian Asset Management LLC now owns 236,647 shares of the company's stock worth $1,494,000 after purchasing an additional 22,569 shares during the last quarter. Finally, EP Wealth Advisors LLC acquired a new stake in LifeVantage during the first quarter worth about $234,000. 27.06% of the stock is owned by hedge funds and other institutional investors.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Further Reading

• Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
• MarketBeat: Week in Review 9/5 – 9/9
• Prepare For A Record-Setting Quarter For Cyber Security Stocks
• The Auto Market Is Slowly Recovering, These Stocks May Outperform
• Is DocuSign On The Verge Of A Major Reversal?
• Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.